• No results found

[PDF] Top 20 A prediction model for progressive disease in systemic sclerosis

Has 10000 "A prediction model for progressive disease in systemic sclerosis" found on our website. Below are the top 20 most common "A prediction model for progressive disease in systemic sclerosis".

A prediction model for progressive disease in systemic sclerosis

A prediction model for progressive disease in systemic sclerosis

... of prediction of pro- gressive disease in the short term in a heterogeneous population with ...of disease duration and subtype, the study population re fl ects the whole population present in a ... See full document

9

Model for Prediction of Progression in Multiple Sclerosis

Model for Prediction of Progression in Multiple Sclerosis

... Multiple sclerosis is an idiopathic inflammatory disease of the central nervous system and the second most common cause of disability in young ...fourteen disease-modifying therapies in MSBase, an ... See full document

6

The role of regional and neuroaxial anesthesia in patients with systemic sclerosis

The role of regional and neuroaxial anesthesia in patients with systemic sclerosis

... Abstract: Systemic sclerosis (SSc), previously known as progressive systemic sclerosis, is a form of scleroderma and a multisystem connective tissue disease which can impact on ... See full document

10

Cognizance, Pharmaceutical Care Manaeuvre and Clinical Pearls of Diffuse Systemic Sclerosis, A Strew of Multiple Systems Fraternization:  A Rare Case Report

Cognizance, Pharmaceutical Care Manaeuvre and Clinical Pearls of Diffuse Systemic Sclerosis, A Strew of Multiple Systems Fraternization: A Rare Case Report

... Systemic sclerosis is an acquired sporadic disease affecting all races ...year. Systemic sclerosis is an uncommon connective tissue disorder characterized by chronic progressive ... See full document

12

A Study of Cardio Pulmonary Manifestations in Systemic Sclerosis

A Study of Cardio Pulmonary Manifestations in Systemic Sclerosis

... Slowly progressive exertional dyspnea is the most common symptom of PAH. The diagnosis of PAH is a process of exclusion. In the absence of other causes, dyspnea should prompt evaluation for PAH in SSc patients, ... See full document

110

Progressive Systemic Sclerosis: A Case Report and Review of  Literature

Progressive Systemic Sclerosis: A Case Report and Review of Literature

... In progressive systemic sclerosis the disease extends to involve the upper extremities, trunk, face, and, finally, the lower extremities, which may sometimes be ... See full document

6

Cardiovascular disease in systemic sclerosis   an emerging association?

Cardiovascular disease in systemic sclerosis an emerging association?

... vascular disease in ...animal model of ...early disease and decrease with increasing disease dura- ...cardiovascular disease, in which a decreased number in the peripheral circulation ... See full document

10

<p>Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease</p>

<p>Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease</p>

... of disease, with approximately 25% of the patients developing sig- ni fi cant pulmonary involvement within 3 years of SSc ...lung disease (ILD) constitutes one of the most common types of direct pulmonary ... See full document

17

Acute Renal Failure during Progressive Systemic Sclerosis in the Regional University Teaching Hospital of Brest La Cavale Blanche (France)

Acute Renal Failure during Progressive Systemic Sclerosis in the Regional University Teaching Hospital of Brest La Cavale Blanche (France)

... rare disease in which visceral manifestations oc- cur, particularly peripheral vascular, digestive, cardiopulmonary and ...this disease required a high dose of corti- costeroid therapy and extra-renal ... See full document

9

Amyotrophic Lateral Sclerosis (ALS) about 2 Observations in the Neurology Department of the University Hospital of Cocody

Amyotrophic Lateral Sclerosis (ALS) about 2 Observations in the Neurology Department of the University Hospital of Cocody

... The progressive profile is hetero- geneous and can schematically determine three different profiles: the decliners rapid patients (approximately 25%); the median survival is less than 12 months of decliners slow ... See full document

6

Esophageal Motor Abnormalities in Children and Adolescents With Scleroderma and Mixed Connective Tissue Disease

Esophageal Motor Abnormalities in Children and Adolescents With Scleroderma and Mixed Connective Tissue Disease

... nective tissue disease, esophageal manometry was per- formed on seven patients with progressive systemic sclerosis, four patients with mixed connective tissue.. disease, and two patients[r] ... See full document

7

Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis

Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis

... Steroid and/or initiation or escalation of immunosuppressive agents is often used (especially with co- existing peripheral myositis) although a good evidence base for this does not exist. The time-course of individual ... See full document

24

Immunosuppression for interstitial lung disease in systemic sclerosis

Immunosuppression for interstitial lung disease in systemic sclerosis

... Systemic sclerosis (SSc) is characterised by obliterative microvasculopathy, activation of the immune system, and fibrosis of the skin and internal ...vascular disease leading to pulmonary arterial ... See full document

8

Amyotrophic lateral sclerosis: update for family physicians.

Amyotrophic lateral sclerosis: update for family physicians.

... Amyotrophic lateral sclerosis is a steadily progressive disease and does not usually have abrupt exacerba- tions. Swallowing gradually becomes more difficult to the point that a gastrostomy tube ... See full document

7

The effect of smoking on the symptoms and progression of multiple sclerosis: a review

The effect of smoking on the symptoms and progression of multiple sclerosis: a review

... Tobacco smoking is one of the main preventable causes of chronic disease and death. Smoking, as an environmental factor, is associated with increased risk of some autoim- mune diseases such as rheumatoid ... See full document

12

Clinical Spectrum and Pulmonary Manifestations of Patients with Anti U1RNP Antibody Status.

Clinical Spectrum and Pulmonary Manifestations of Patients with Anti U1RNP Antibody Status.

... The incidence of ILD in mixed connective tissue depends on the selection of patients and the method used for diagnosing the lung disorder. The prevalence of interstitial lung disease is found to be higher than ... See full document

84

Bench to bedside review of myositis autoantibodies

Bench to bedside review of myositis autoantibodies

... rapidly progressive interstitial lung disease; CADM: clinically amyopathic dermatomyositis; TIF1: transcription intermediary factors-1; TRIM: tripartite motif-containing proteins; NXP-2: nuclear matrix ... See full document

17

TOLERABILITY OF LITHIUM CARBONATE ASSOCIATED TO RILUZOLE IN AMYOTROPHIC LATERAL SCLEROSIS

TOLERABILITY OF LITHIUM CARBONATE ASSOCIATED TO RILUZOLE IN AMYOTROPHIC LATERAL SCLEROSIS

... Secondary outcome measures supported the equivalence of lithium and riluzole based upon disease progression, as measured by the ALSFRS, neurophysiological measures, clinical parameters and vital capacity. ... See full document

15

Vascular involvement in systemic sclerosis (scleroderma)

Vascular involvement in systemic sclerosis (scleroderma)

... The degree of perivascular and tissue accumulation of T cells, B cells, monocytes, natural killer (NK) cells, and mast cells is variable and often present early in the disease. The cytokines, growth factors, ... See full document

21

Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases

Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases

... tially systemic disease characterized by an inflammatory, symmetric, additive and erosive arthritis affecting about 1% of the population of developed countries ...the disease is currently not fully ... See full document

11

Show all 10000 documents...